The metabolic product of an anticancer drug demonstrates potential activity in neurons derived from Parkinson’s patients and a synergistic action, together with the original drug, in prostate cancer cells.
An anticancer drug opens a new path for the treatment of Parkinson’s Read More »
The association based in Cambrils visited yesterday the new IDIBELL neurological diseases laboratory and presented a generous solidarity check
Swim for ELA, IDIBELL and Bellvitge Hospital, together against ALS Read More »
The IDIBELL Psychiatry and Mental Health group has carried out the first study that relates clinical information with long-term prognosis through machine learning.
New machine learning tool that predicts the evolution of OCD patients Read More »
An international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood.
Alterations in the blood immune system found to increase cancer risk Read More »
The event will take place at the Barradas Auditorium in L’Hospitalet de Llobregat on Thursday, February 8, at 7 p.m. In its 7th edition, the sLHam will once again be starred by six scientists from IDIBELL and two sLHamers from the Bellvitge Institute: a student and a science teacher.
A research team has shown how the presence of type 2 diabetes increased the likelihood of more depressive symptoms, and in turn, the higher the levels of depressive symptoms, the higher the prevalence of type 2 diabetes.
Type 2 diabetes linked to increased depressive symptoms Read More »
This grant allows the UICEC to remain one of the 27 clinical research support units that make up the ISCIII platform.
The association based in the Baix Llobregat has been collaborating with IDIBELL since 2016, collecting funds for cancer research.
Collaborative success in advancing stroke neuroprotection
The renowned Dr. Kerri Johannson, a member of the Snyder Institute for Chronic Diseases at Canada’s University of Calgary, gave an IDIBELL seminar on January 12 at the Bellvitge Campus on the impact of environmental exposures on patients with pulmonary fibrosis.
